Journal article · 2018 · Open access
Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials
Value in Health, 21, S256–S257 · Published 1 May 2018 · DOI 10.1016/j.jval.2018.04.1783
In brief
“Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials” is a 2018 journal article by Chenglong Han and 4 co-authors, published in Value in Health. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read at Value in Health.
- Citations
- 0
- Authors
- 5
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Han, C., Song, M., Wasfi, Y. S., Li, S., & Needleman, H. (2018). Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials. Value in Health, 21, S256–S257. https://doi.org/10.1016/j.jval.2018.04.1783
MLA 9
Han, Chenglong, et al. “Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials.” Value in Health, vol. 21, 2018, pp. S256–S257. https://doi.org/10.1016/j.jval.2018.04.1783.
Chicago
Han, Chenglong, Michael Song, Yasmine S. Wasfi, S Li, and H Needleman. 2018. “Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials.” Value in Health 21: S256–S257. https://doi.org/10.1016/j.jval.2018.04.1783.
Harvard
Han, C. et al. (2018) ‘Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials’, Value in Health, 21, pp. S256–S257. doi:10.1016/j.jval.2018.04.1783.
IEEE
C. Han, M. Song, Y. S. Wasfi, S. Li, and H. Needleman, “Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials,” Value in Health, vol. 21, pp. S256–S257, 2018, doi: 10.1016/j.jval.2018.04.1783.
BibTeX
@article{han2018development,
title = {{Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials}},
author = {Han, Chenglong and Song, Michael and Wasfi, Yasmine S. and Li, S and Needleman, H},
journal = {Value in Health},
year = {2018},
volume = {21},
pages = {S256--S257},
doi = {10.1016/j.jval.2018.04.1783},
url = {https://doi.org/10.1016/j.jval.2018.04.1783}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- psoriasis
- patient-reported outcomes
- psoriasis severity
- PASI
- guselkumab
- adalimumab
- health-related quality of life
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Han, C., Song, M., Wasfi, Y. S., Li, S., & Needleman, H. (2018). Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials. Value in Health, 21, S256–S257. https://doi.org/10.1016/j.jval.2018.04.1783
How many times has this paper been cited?
0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Value in Health: sign in and open the full text from this page.
Who wrote this paper?
Chenglong Han, Michael Song, Yasmine S. Wasfi, S Li, H Needleman.
What is the DOI of this paper?
10.1016/j.jval.2018.04.1783, permanently at https://doi.org/10.1016/j.jval.2018.04.1783. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.